Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

A rechallenge protocol for successfully re-instituting Fabrazyme therapy in patients with previous infusion-associated hypersensitivity reactions

A rechallenge protocol for successfully re-instituting Fabrazyme therapy in patients with previous infusion-associated hypersensitivity reactions. European Study Group on Lysosomal Disorders [ESGLD] Workshop. 2005.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.